A Long-term Observational Study in Participants Who Have Received PBGENE-HBV

Enrolling by invitation

Conditions studied: Chronic HBV Infection

In brief

Participants who received at least one dose of PBGENE-HBV will be enrolled in this LTFU study.

Key facts

Study ID

NCT07254208

Run by

Precision BioSciences, Inc.

People needed

45

Starts

2025-12-25

Expected to finish

2040-06-01

Last updated by the study team

2026-04-22

Who can join

Age: 19 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participant has received at least 1 dose of PBGENE-HBV investigational product in a prior clinical study
• Participant, or their legally authorized representative, has provided signed informed consent.

You may not qualify if…

• N/A

Where it is running

• Massachusetts General Hospital/Harvard University — Boston, Massachusetts, United States
• Queen Mary Hospital, University of Hong Kong — Hong Kong, Hong Kong, Hong Kong
• ICS ARENSIA Exploratory Medicine SRL — Chisinau, Moldova, Moldova
• New Zealand Clinical Research — Auckland, New Zealand, New Zealand

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.